Alnylam Pharmaceuticals
ALNY
#443
Rank
C$72.97 B
Marketcap
C$552.36
Share price
1.06%
Change (1 day)
60.55%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company